A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer
A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer
Recruiting · NCT05659732 · Registry updated 2025-07-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2025-07-31 | NCT05659732 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| PharmaEngine | 3 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chang Gung Memorial Hospital- Linkou | Taipei | Taiwan | 1 |
| China Medical University Hospital | Taichung | Taiwan | 54 |
| Kaohsiung Medical University Chung-Ho Memorial Hospital | Kaohsiung City | Taiwan | 48 |
| Monash Medical Centre | Clayton | Australia | 60 |
| National Taiwan University Hospital | Taipei | Taiwan | 203 |